Christine D Palmer

Christine D Palmer

Harvard University

H-index: 20

North America-United States

About Christine D Palmer

Christine D Palmer, With an exceptional h-index of 20 and a recent h-index of 14 (since 2020), a distinguished researcher at Harvard University,

His recent articles reflect a diverse array of research interests and contributions to the field:

Homologous adenoviral vaccination

Infectious disease antigens and vaccines

MTHFR C677 T polymorphism & depression

A shared neoantigen vaccine combined with immune checkpoint blockade for advanced metastatic solid tumors: phase 1 trial interim results

GRT-R910: a self-amplifying mRNA SARS-CoV-2 vaccine boosts immunity for≥ 6 months in previously-vaccinated older adults

HLA-DR-restricted CD4 T cell responses to KRAS G12C in healthy donors linked to bacterial mimotope: lessons for KRAS neoantigen vaccines in cancer patients

Shared neoantigen vaccines

2346. Preliminary results of durable immune response induced by a self-amplifying mRNA (samRNA) SARS-CoV-2 vaccine candidate, GRT-R910, in adults previously vaccinated with …

Christine D Palmer Information

University

Position

Harvard Medical School; Massachusetts General Hospital; Ragon Institute of MGH, MIT and Harvard;

Citations(all)

2289

Citations(since 2020)

1106

Cited By

1442

hIndex(all)

20

hIndex(since 2020)

14

i10Index(all)

31

i10Index(since 2020)

19

Email

University Profile Page

Harvard University

Google Scholar

View Google Scholar Profile

Top articles of Christine D Palmer

Title

Journal

Author(s)

Publication Date

Homologous adenoviral vaccination

2024/3/21

Infectious disease antigens and vaccines

2024/2/15

MTHFR C677 T polymorphism & depression

The American Journal of the Medical Sciences

KL Romanoff

C Palmer

J Nimmagadda

C Martin

2024/2/1

A shared neoantigen vaccine combined with immune checkpoint blockade for advanced metastatic solid tumors: phase 1 trial interim results

Nature Medicine

Amy R Rappaport

Chrisann Kyi

Monica Lane

Meghan G Hart

Melissa L Johnson

...

2024/3/27

GRT-R910: a self-amplifying mRNA SARS-CoV-2 vaccine boosts immunity for≥ 6 months in previously-vaccinated older adults

Nature Communications

Christine D Palmer

Ciaran D Scallan

Lauren D Kraemer Tardif

Melissa A Kachura

Amy R Rappaport

...

2023/6/6

HLA-DR-restricted CD4 T cell responses to KRAS G12C in healthy donors linked to bacterial mimotope: lessons for KRAS neoantigen vaccines in cancer patients

Cancer Research

Christine D Palmer

Meghan G Hart

Sonia Kounlavouth

Harshni Venkatraman

Lauren D Kraemer

...

2023/4/4

Shared neoantigen vaccines

2023/1/19

2346. Preliminary results of durable immune response induced by a self-amplifying mRNA (samRNA) SARS-CoV-2 vaccine candidate, GRT-R910, in adults previously vaccinated with …

Open Forum Infectious Diseases

Alison Uriel

Pedro Garbes

A Nagare

JC Kuan

Christine Palmer

...

2023/12

2372. Preliminary evidence of durable immune responses induced by self-amplifying mRNA (samRNA) vaccine candidates against SARS-CoV-2 in vaccine-naive South African population

Open Forum Infectious Diseases

A Koen

E Mitha

J Allagappen

A Nagare

M Dhar

...

2023/12

Multiepitope vaccine cassettes

2023/10/3

A novel low-dose self-amplifying mRNA vaccine (GRT-R910) induces strong and broad boost in cellular and humoral immune response following primary series with a chimpanzee …

Open Forum Infectious Diseases

T Turgut

U Ahmed

M Kachura

L Kraemer

C Nganje

...

2022

Individualized, heterologous chimpanzee adenovirus and self-amplifying mRNA neoantigen vaccine for advanced metastatic solid tumors: phase 1 trial interim results

Nature medicine

Christine D Palmer

Amy R Rappaport

Matthew J Davis

Meghan G Hart

Ciaran D Scallan

...

2022/8

Lower doses of self-amplifying mRNA drive superior neoantigen-specific CD8 T cell responses in cancer patients versus high doses

Cancer Research

Christine D Palmer

Amy R Rappaport

Meghan G Hart

Lauren D Kraemer

Sonia Kounlavouth

...

2022/6/15

Optimization of shared neoantigen vaccine design to increase vaccine potency: From bench to bedside and back

Amy R Rappaport

Christine D Palmer

Annie Shen

Claudia X Dominguez

Meghan G Hart

...

2022/6/15

Selection of t cell receptors

2022/5/19

IDENTIFICATION OF NEOANTIGENS USING A CLASS II MHC MODEL

2022/12/21

Identification of neoantigens with mhc class ii model

2022/5/19

1974. Title: A novel low-dose self-amplifying mRNA vaccine (GRT-R910) induces strong and broad boost in cellular and humoral immune response following primary series with a …

Open Forum Infectious Diseases

Tolga Turgut

Uzma Ahmed

Melissa Kachura

Lauren Kraemer

Charmaine Nganje

...

2022/12/1

Neoantigen identification for t-cell therapy

2021/6/30

See List of Professors in Christine D Palmer University(Harvard University)